Viatris, Inc. Hits New 52-Week High at USD 16.46

Viatris, Inc., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 16.46 on February 25, 2026. This achievement marks a remarkable 53.0% increase in the stock's performance over the past year, significantly outpacing the S&P 500's growth of 12.95% during the same period. With a market capitalization of USD 18,728 million, Viatris operates in a competitive industry characterized by innovation and evolving market dynamics. The company's price-to-earnings (P/E) ratio stands at 44.00, reflecting its valuation in the context of its earnings. Additionally, Viatris boasts a notable dividend yield of 69.40%, which may appeal to income-focused investors. Despite a return on equity of -2.14% and a debt-to-equity ratio of 0.88, the stock's recent performance underscores its resilience in the market. The previous 52-week low was recorded at USD 6.85, highlighting the significant upward trajectory the stock has experienced.